Creatine and Creatinine Metabolism - Physiological Reviews

1202 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
dazo[4,5-g]quinoxaline (7,9-DiMeIgQx), present in beef extract.
Carcinogenesis 15: 1151–1154, 1994.
711. ODOOM JE, KEMP GJ, AND RADDA GK. The regulation of total
creatine content in a myoblast cell line. Mol Cell Biochem 158:
179–188, 1996.
712. OGAWA H, DATE T, GOMI T, KONISHI K, PITOT HC, CANTONI
GL, AND FUJIOKA M. Molecular cloning, sequence analysis, and
expression in Escherichia coli of the cDNA for guanidinoacetate
methyltransferase from rat liver. Proc Natl Acad Sci USA 85:
694–698, 1988.
713. OGAWA H, ISHIGURO Y, AND FUJIOKA M. Guanidoacetate methyltransferase
from rat liver: purification, properties, and evidence
for the involvement of sulfhydryl groups for activity. Arch Biochem
Biophys 226: 265–275, 1983.
714. OGAWA J, KIM JM, NIRDNOY W, AMANO Y, YAMADA H, AND
SHIMIZU S. Purification and characterization of an ATP-dependent
amidohydrolase, N-methylhydantoin amidohydrolase, from
Pseudomonas putida 77. Eur J Biochem 229: 284–290, 1995.
715. OGAWA J, NIRDNOY W, TABATA M, YAMADA H, AND SHIMIZU S.
A new enzymatic method for the measurement of creatinine involving
a novel ATP-dependent enzyme, N-methylhydantoin
amidohydrolase. Biosci Biotechnol Biochem 59: 2292–2294, 1995.
716. OGIMOTO G, OZAWA S, MAEBA T, OWADA S, AND ISHIDA M.
31 P-NMR study for the energy metabolism of skeletal muscle in
chronic haemodialysis patients. In: Guanidino Compounds in
Biology and Medicine, edited by P. P. De Deyn, B. Marescau, V.
Stalon, and I. A. Qureshi. London: Libbey, 1992, p. 281–285.
717. O’GORMAN E, BEUTNER G, DOLDER M, KORETSKY AP,
BRDICZKA D, AND WALLIMANN T. The role of creatine kinase in
inhibition of mitochondrial permeability transition. FEBS Lett
414: 253–257, 1997.
718. O’GORMAN E, BEUTNER G, WALLIMANN T, AND BRDICZKA D.
Differential effects of creatine depletion on the regulation of
enzyme activities and on creatine-stimulated mitochondrial respiration
in skeletal muscle, heart, and brain. Biochim Biophys Acta
1276: 161–170, 1996.
719. O’GORMAN E, FUCHS K-H, TITTMANN P, GROSS H, AND WAL-
LIMANN T. Crystalline mitochondrial inclusion bodies isolated
from creatine depleted rat soleus muscle. J Cell Sci 110: 1403–
1411, 1997.
720. O’GORMAN E, PIENDL T, MÜLLER M, BRDICZKA D, AND WAL-
LIMANN T. Mitochondrial intermembrane inclusion bodies: the
common denominator between human mitochondrial myopathies
and creatine depletion, due to impairment of cellular energetics.
Mol Cell Biochem 174: 283–289, 1997.
721. OGURI A, NAGAO M, ARAKAWA N, SUGIMURA T, AND WAKABA-
YASHI K. Mutagen formation after heating of mixtures of guanidino
compounds, amino acids and glucose. Proc Jpn Acad 70:
67–70, 1994.
722. OHASHI F, AWAJI T, SHIMADA T, AND SHIMADA Y. Plasma
methylguanidine and creatinine concentrations in cats with experimentally
induced acute renal failure. J Vet Med Sci 57: 965–
966, 1995.
723. OHGAKI H, TAKAYAMA S, AND SUGIMURA T. Carcinogenicities
of heterocyclic amines in cooked food. Mutat Res 259: 399–410,
1991.
724. OHIRA Y, ISHINE S, TABATA I, KURATA H, WAKATSUKI T,
SUGAWARA S, YASUI W, TANAKA H, AND KURODA Y. Noninsulin
and non-exercise related increase of glucose utilization in
rats and mice. Jpn J Physiol 44: 391–402, 1994.
725. OHIRA Y, KANZAKI M, AND CHEN C-S. Intramitochondrial inclusions
caused by depletion of creatine in rat skeletal muscles. Jpn
J Physiol 38: 159–166, 1988.
726. OHIRA Y, SAITO K, WAKATSUKI T, YASUI W, SUETSUGU T,
NAKAMURA K, TANAKA H, AND ASAKURA T. Responses of �-adrenoceptor
in rat soleus to phosphorus compound levels and/or
unloading. Am J Physiol Cell Physiol 266: C1257–C1262, 1994.
727. OHIRA Y, WAKATSUKI T, INOUE N, NAKAMURA K, ASAKURA T,
IKEDA K, TOMIYOSHI T, AND NAKAJOH M. Non-exercise-related
stimulation of mitochondrial protein synthesis in creatine-depleted
rats. Med Sport Sci 37: 318–323, 1992.
728. OHKOSHI N, MIZUSAWA H, FUJITA T, AND SHOJI S. Histological
determination of nitric oxide synthase (NOS) and NADPH-diaph-
orase in ragged-red fibers from patients with mitochondrial encephalomyopathies.
J Neurol Sci 149: 151–156, 1997.
729. OKA I, YOSHIMOTO T, RIKITAKE K, OGUSHI S, AND TSURU D.
Sarcosine dehydrogenase from Pseudomonas putida: purification
and some properties. Agric Biol Chem 43: 1197–1203, 1979.
730. OKADA Y AND YONEDA K. Effects of accumulation of phosphocreatine
on the survival time of thin hippocampal slices from the
guinea pig during deprivation of both oxygen and glucose. Neurosci
Lett 41: 125–131, 1983.
731. OKONOGI H, USHIJIMA T, SHIMIZU H, SUGIMURA T, AND NA-
GAO M. Induction of aberrant crypt foci in C57BL/6N mice by
2-amino-9H-pyrido[2,3-b]indole (A�C) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline
(MeIQx). Cancer Lett 111: 105–109,
1997.
732. OLDFORS A, LARSSON N-G, LINDBERG C, AND HOLME E. Mitochondrial
DNA deletions in inclusion body myositis. Brain 116:
325–336, 1993.
733. ÖÖPIK V, PÄÄSUKE M, TIMPMANN S, MEDIJAINEN L, ERELINE
J, AND SMIRNOVA T. Effect of creatine supplementation during
rapid body mass reduction on metabolism and isokinetic muscle
performance capacity. Eur J Appl Physiol 78: 83–92, 1998.
734. ÖÖPIK V, TIMPMANN S, MEDIJAINEN L, AND ALEKSEJEVA T.
Effect of creatine administration on blood urea level and postexercise
glycogen repletion in liver and skeletal muscle in rats. Ann
Nutr Metab 40: 359–363, 1996.
735. ORITA Y, ANDO A, TSUBAKIHARA Y, MIKAMI H, KIKUCHI T,
NAKATA K, AND ABE H. Tissue and blood cell concentration of
methylguanidine in rats and patients with chronic renal failure.
Nephron 27: 35–39, 1981.
736. ORITA Y, TSUBAKIHARA Y, ANDO A, NAKATA K, TAKAMITSU
Y, FUKUHARA Y, AND ABE H. Effect of arginine or creatinine
administration on the urinary excretion of methylguanidine.
Nephron 22: 328–336, 1978.
737. OSBAKKEN M, DOUGLAS PS, IVANICS T, ZHANG D, AND VAN
WINKLE T. Creatine kinase kinetics studied by phosphorus-31
nuclear magnetic resonance in a canine model of chronic hypertension-induced
cardiac hypertrophy. J Am Coll Cardiol 19: 223–
228, 1992.
738. OSBAKKEN M, ITO K, ZHANG D, PONOMARENKO I, IVANICS T,
JAHNGEN EGE, AND COHN M. Creatine and cyclocreatine effects
on ischemic myocardium: 31 P nuclear magnetic resonance evaluation
of intact heart. Cardiology 80: 184–195, 1992.
739. OSBAKKEN MD. Metabolic regulation of in vivo myocardial contractile
function: multiparameter analysis. Mol Cell Biochem 133:
13–37, 1994.
740. OTSU N, YAMAGUCHI I, KOMATSU E, AND MIYAZAWA K.
Changes in creatine kinase M localization in acute ischemic myocardial
cells. Immunoelectron microscopic studies. Circ Res 73:
935–942, 1993.
741. OTTEN JV, FITCH CD, WHEATLEY JB, AND FISCHER VW. Thyrotoxic
myopathy in mice: accentuation by a creatine transport
inhibitor. Metabolism 35: 481–484, 1986.
742. OUELLET M AND SHOUBRIDGE EA. Phosphocreatine-dependent
protein phosphorylation in rat skeletal muscle. Biochem J 284:
115–122, 1992.
743. VERVIK E AND GUSTAFSSON J-Å. Cooked-food mutagens: current
knowledge of formation and biological significance. Mutagenesis
5: 437–446, 1990.
744. VERVIK E, KLEMAN M, BERG I, AND GUSTAFSSON J-Å. Influence
of creatine, amino acids and water on the formation of the mutagenic
heterocyclic amines found in cooked meat. Carcinogenesis
10: 2293–2301, 1989.
745. OWENS CWI, ALBUQUERQUE ZP, AND TOMLINSON GM. In vitro
metabolism of creatinine, methylamine and amino acids by intestinal
contents of normal and uraemic subjects. Gut 20: 568–574,
1979.
746. OZASA H, HORIKAWA S, AND OTA K. Methylguanidine synthase
from rat kidney is identical to long-chain L-2-hydroxy acid oxidase.
Nephron 68: 279, 1994.
747. OZASA H, WATANABE T, NAKAMURA K, FUKUNAGA Y,
IENAGA K, AND HAGIWARA K. Changes in serum levels of creatol
and methylguanidine in renal injury induced by lipid peroxide